ABT-414, an Antibody–Drug Conjugate Targeting a Tumor-Selective EGFR Epitope
Year: 2016
Type: article
Source: Molecular Cancer Therapeutics
Institutions: AbbVie (United States), Jackson Laboratory
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2290428590
